Kaitlyn J. Cartwright, MD

Assistant Professor of Neurology

Division of Child Neurology

University of Kentucky

Carlos Palomino, MD

PGY4 Resident in Child Neurology

University of Kentucky

Tuesday, September 23, 2025

8:00 - 8:50 AM EDT

Zoom only: https://uky.zoom.us/j/81485627103

Upon completion of this activity, participants will be able to:

1. Review the variability of neurologic presentations which can be seen in neurologic involvement of sarcoidosis.
2. Describe the diagnostic criteria for neurosarcoidosis, including the differences between possible, probably, and definite neurosarcoidosis.
3. Discuss factors leading to delay to diagnosis in sarcoidosis as well as healthcare disparities that exist in sarcoidosis.

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Kaitlin J. Cartwright, MD, faculty for this educational event, is a Co-Investigator for clinical trials for Sanofi and Immunic Therapeutics.

All of the relevant financial relationships listed for this individual have been mitigated.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.